• MLH1 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Carnitine Palmitoyltransferase 1A (CPT1A) Mutation Analysis
  • Factor II (Prothrombin) Mutation
  • Strongyloides Antibody, IgG
  • Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)
  • Hemophilia A (F8) Gene Mutation Analysis
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
  • Anti-SARS-CoV-2 (Coronavirus), IgG
  • Hepatitis A Virus (HAV) Antibody Total
  • Electrophoresis, Protein, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 125
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 125
Medical Test

Additional Testing

Carcinoembryonic antigen (CEA), CA 15-3, CA 19-9, Follicle Stimulating Hormone, Luteinizing Hormone, HCG, Progesterone, HE4.